Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Market Cap

Corcept Therapeutics has a market cap or net worth of $4.17 billion as of February 17, 2026. Its market cap has decreased by -43.08% in one year.

• Market Cap: 4.17B
• Enterprise Value: 3.67B
• 1-Year Change: -43.08%
• Ranking: #1510
• Category: Mid-Cap
• Stock Price: $39.63

Market Cap Chart

Since April 14, 2004, Corcept Therapeutics's market cap has increased from $283.00M to $4.17B, an increase of 1,373.01%. That is a compound annual growth rate of 13.10%.

Market Cap History

Date	Market Cap	% Change
Feb 13, 2026	4.20B	14.86%
Dec 31, 2025	3.66B	-30.67%
Dec 31, 2024	5.28B	57.69%
Dec 29, 2023	3.35B	53.13%
Dec 30, 2022	2.19B	-4.35%
Dec 31, 2021	2.29B	-24.78%
Dec 31, 2020	3.04B	119.78%
Dec 31, 2019	1.38B	-10.36%
Dec 31, 2018	1.54B	-25.15%
Dec 29, 2017	2.06B	155.69%
Dec 30, 2016	806.10M	48.81%
Dec 31, 2015	541.70M	78.43%
Dec 31, 2014	303.60M	-5.24%
Dec 31, 2013	320.40M	124.53%
Dec 31, 2012	142.70M	-50.47%
Dec 30, 2011	288.10M	3.11%
Dec 31, 2010	279.40M	60.85%
Dec 31, 2009	173.70M	248.10%
Dec 31, 2008	49.90M	-59.17%
Dec 31, 2007	122.20M	336.43%
Dec 29, 2006	28.00M	-66.22%
Dec 30, 2005	82.90M	-41.54%
Dec 31, 2004	141.80M	-49.89%
Apr 14, 2004	283.00M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Apogee Therapeutics	4.70B
Amicus Therapeutics	4.49B
Crinetics Pharmaceuticals	4.48B
CG Oncology	4.35B
Terns Pharmaceuticals	4.31B
TG Therapeutics	4.24B
Arcellx	4.05B
NewAmsterdam Pharma Company	4.00B